$RIVF
Rivulet Entertainment, Inc.

2022 Q4 Form 10-Q Financial Statement

#000137647422000453 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue $0.00 $0.00 $0.00
YoY Change
Gross Profit $0.00 $0.00 $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $8.000K $9.200K $14.92K
YoY Change -72.35% -38.34% 58.22%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $0.00 $3.680K
YoY Change -100.0% -100.0% 0.0%
% of Gross Profit
Operating Expenses $8.360K $9.555K $15.40K
YoY Change -71.67% -37.95% 57.3%
Operating Profit -$8.360K -$9.555K -$15.40K
YoY Change -71.67% -37.95% 57.3%
Interest Expense -$140.00 $579.00 -$590.00
YoY Change -73.08% -198.14% 18.0%
% of Operating Profit
Other Income/Expense, Net -$579.00 -$594.00
YoY Change -2.53%
Pretax Income -$8.490K -$10.13K -$16.00K
YoY Change -71.74% -36.66% 55.49%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$8.490K -$10.13K -$16.00K
YoY Change -71.74% -36.66% 55.49%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 -$35.55 -$56.86
COMMON SHARES
Basic Shares Outstanding 284.9M shares 284.9M shares 280.5M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $140.00 $150.00 $5.230K
YoY Change -98.85% -97.13% 833.93%
Cash & Equivalents $138.00 $152.00 $5.230K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $138.00 $152.00 $5.230K
YoY Change -98.86% -97.09% 833.93%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $2.960K
YoY Change -100.0% -83.24%
TOTAL ASSETS
Total Short-Term Assets $138.00 $152.00 $5.230K
Total Long-Term Assets $0.00 $0.00 $2.960K
Total Assets $138.00 $152.00 $8.190K
YoY Change -98.86% -98.14% -55.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $101.8K $104.0K $90.86K
YoY Change 0.59% 14.45% 44.57%
Accrued Expenses $177.8K $177.8K $175.8K
YoY Change 0.84% 1.13% 1.14%
Deferred Revenue
YoY Change
Short-Term Debt $19.94K $19.94K $19.94K
YoY Change 0.0% 0.0% -3.62%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $343.7K $335.3K $305.2K
YoY Change 10.12% 9.86% 18.56%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $343.7K $335.3K $305.2K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $343.7K $335.3K $305.2K
YoY Change 10.12% 9.86% 18.56%
SHAREHOLDERS EQUITY
Retained Earnings -$8.632M -$8.624M
YoY Change 0.57%
Common Stock $284.9K $284.9K
YoY Change 0.12%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$343.6K -$335.1K -$297.0K
YoY Change
Total Liabilities & Shareholders Equity $138.00 $152.00 $8.190K
YoY Change -98.86% -98.14% -55.05%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$8.490K -$10.13K -$16.00K
YoY Change -71.74% -36.66% 55.49%
Depreciation, Depletion And Amortization $0.00 $0.00 $3.680K
YoY Change -100.0% -100.0% 0.0%
Cash From Operating Activities -$10.71K -$9.160K -$12.25K
YoY Change -34.13% -25.22% 114.16%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $17.00K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.70K 8.690K 17.29K
YoY Change -53.84% -49.74% 2205.33%
NET CHANGE
Cash From Operating Activities -10.71K -9.160K -12.25K
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 10.70K 8.690K 17.29K
Net Change In Cash -10.00 -470.0 5.040K
YoY Change -100.14% -109.33% -201.41%
FREE CASH FLOW
Cash From Operating Activities -$10.71K -$9.160K -$12.25K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-52390
dei Entity Registrant Name
EntityRegistrantName
Advanced Voice Recognition Systems, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0511932
dei Entity Address Address Line1
EntityAddressAddressLine1
7659 E. Wood Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Scottsdale
dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85260
dei City Area Code
CityAreaCode
(480)
dei Local Phone Number
LocalPhoneNumber
704-4183
dei Security12b Title
Security12bTitle
Common Stock par value $0.001 per share
dei Trading Symbol
TradingSymbol
AVOI
dei Security Exchange Name
SecurityExchangeName
NONE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
284920269 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
152 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12148 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
152 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
12148 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
0 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
0 usd
CY2022Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
0 usd
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
0 usd
CY2022Q3 us-gaap Assets
Assets
152 usd
CY2021Q4 us-gaap Assets
Assets
12148 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
103992 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
101182 usd
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
162381 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
162380 usd
CY2022Q3 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
19935 usd
CY2021Q4 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
19935 usd
CY2022Q3 fil Advance From Related Party
AdvanceFromRelatedParty
33493 usd
CY2021Q4 fil Advance From Related Party
AdvanceFromRelatedParty
14700 usd
CY2022Q3 us-gaap Interest Payable Current
InterestPayableCurrent
15.450 usd
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
13955 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
335251 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
312152 usd
CY2022Q3 us-gaap Liabilities
Liabilities
335251 usd
CY2021Q4 us-gaap Liabilities
Liabilities
312152 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
547500000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
547500000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
284920269 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
284920269 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
284586935 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
284586935 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
284920 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
284587 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8003500 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7998833 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8623519 usd
CY2021Q3 us-gaap Other General Expense
OtherGeneralExpense
482 usd
us-gaap Other General Expense
OtherGeneralExpense
1346 usd
us-gaap Other General Expense
OtherGeneralExpense
1471 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
9555 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
15404 usd
us-gaap Operating Expenses
OperatingExpenses
38277 usd
us-gaap Operating Expenses
OperatingExpenses
51605 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9555 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-15404 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8583424 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-335099 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-300004 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
152 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12148 usd
CY2022Q3 us-gaap Revenues
Revenues
0 usd
CY2021Q3 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
us-gaap Cost Of Revenue
CostOfRevenue
0 usd
us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
0 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Gross Profit
GrossProfit
0 usd
CY2022Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
25 usd
CY2021Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
25 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
4071 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
117 usd
CY2022Q3 us-gaap Professional Fees
ProfessionalFees
6726 usd
CY2021Q3 us-gaap Professional Fees
ProfessionalFees
8900 usd
us-gaap Professional Fees
ProfessionalFees
26397 usd
us-gaap Professional Fees
ProfessionalFees
32565 usd
CY2022Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
2447 usd
CY2021Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
5997 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
6463 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
17452 usd
CY2022Q3 us-gaap Other General Expense
OtherGeneralExpense
357 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-38277 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-51605 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
579 usd
CY2021Q3 us-gaap Interest Expense
InterestExpense
594 usd
us-gaap Interest Expense
InterestExpense
1818 usd
us-gaap Interest Expense
InterestExpense
1741 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-579 usd
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-594 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1818 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1741 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-10134 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-15998 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-40095 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-53346 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
0 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-10134 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-15998 usd
us-gaap Net Income Loss
NetIncomeLoss
-40095 usd
us-gaap Net Income Loss
NetIncomeLoss
-53346 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
284920269 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
280506935 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
284920269 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
280446935 shares
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-262623 usd
CY2021Q1 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
0 usd
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-18900 usd
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-281523 usd
CY2021Q2 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
2000 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-18448 usd
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-297971 usd
CY2021Q3 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
17000 usd
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-15998 usd
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-269969 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-300004 usd
CY2022Q1 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
5000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-20183 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-315187 usd
CY2022Q2 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
0 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-9778 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-324965 usd
CY2022Q3 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
0 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-10134 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-335099 usd
us-gaap Profit Loss
ProfitLoss
-40095 usd
us-gaap Profit Loss
ProfitLoss
-53346 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
0 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11028 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4306 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
14211 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-35789 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-28107 usd
us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
19000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
18793 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
13990 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
23793 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
32990 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-11996 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4883 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12148 usd
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
348 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
152 usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5231 usd
us-gaap Interest Paid
InterestPaid
1495 usd
us-gaap Interest Paid
InterestPaid
1495 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Nature Of Operations
NatureOfOperations
<p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify"><b>Note 1.     Nature of Operations</b></p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify"><b><i>Company Overview</i></b></p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify">The operations of Advanced Voice Recognition Systems, Inc. (“AVRS” or the “Company”), http://www.avrsys.com, commenced in 1994 with a predecessor entity called NCC, Inc. NCC, Inc. was incorporated on March 15, 1994 in the State of Ohio. NCC, Inc. operated as a software and hardware development company that marketed voice recognition and transcription products for commercial applications.</p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify">In May 2000, WG Investments, LLC acquired the assets of NCC, Inc. and subsequently changed its name to NCC, LLC. NCC, LLC (also a predecessor to AVRS) continued the operations of NCC, Inc. until approximately December 31, 2001, when shifts in the industry’s markets caused NCC, LLC to suspend its operations.</p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify">AVRS was incorporated in the State of Colorado on July 7, 2005. In September 2005, the members of NCC, LLC transferred all of their membership interests in NCC, LLC to AVRS in exchange for 93,333,333 shares (post-recapitalization) of AVRS common stock. In December 2005, the Board of Directors approved a 1.5-to-1 stock split issuing 46,666,667 common shares (post-recapitalization), which increased the number of common shares outstanding to 140 million shares (post-capitalization). Following the incorporation of AVRS, the Company initiated a new business plan and intends to continue its operations in the voice recognition and transcription industry.</p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify">AVRS is a software development company specializing in speech recognition technologies. AVRS has successfully obtained patent protection of its proprietary technology (refer to Note 3, Intangible Assets).   The Company continues to explore all options to monetize and enforce our patent portfolio through patent enforcement and licensing of the six patents issued. </p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify"><b><i>Stock Purchase Agreements</i></b></p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify">During the nine months ended September 30, 2022, the Company entered into a Stock Purchase Agreement for the private sale to one person or entity of an aggregate of 333,334 shares of the common stock for aggregate proceeds of $5,000. Full payment was received in the period. During the year ended December 31, 2021 the Company entered into Stock Purchase Agreements for the private sale to five persons or entities of an aggregate of 4,200,000 shares of the common stock for aggregate proceeds of $46,000, full payment of which was received in the period. </p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify"><b><i>Commitments and Contingencies</i></b></p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify">On April 20, 2015 Advanced Voice Recognition Systems, Inc. (“AVRS”) entered into a Material Letter Agreement with an unrelated third party (“AIP”) in which they promise to pay to patent legal counsel funds to continue prosecuting Patents on behalf of AVRS.  AVRS promises to pay AIP, or to such other holder of this promissory note (Note) as designate, the principal, together with a premium of ten percent (10%) of Principle and two percent (2%) of proceeds received by Company from a Monetization Event initiated by AIP.  Interest was accrued and reported at September 30, 2022. </p> <p style="font:11pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify">On November 1, 2016, Advanced Voice Recognition Systems, Inc. (“<span style="border-bottom:1px solid #000000">AVRS</span>”) entered into a Contingent Fee Agreement (the “<span style="border-bottom:1px solid #000000">Agreement</span>”) with Legal Representation pursuant to which they will represent AVRS in connection with investigating and asserting claims relating to certain patents, including the negotiation of license agreements and the filing and prosecution of lawsuits, against any potential infringers of rights associated with such patents (the “<span style="border-bottom:1px solid #000000">Patent Rights</span>”).  Legal representation will handle licensing and litigation activities under the Agreement on a contingent fee basis.  The fee will depend upon whether AVRS recovers any sums by way of licensing, settlement, trial or otherwise with respect to the Patent Rights.  On June 6, 2017 AVRS and Legal Representation revised the Contingent Fee Agreement as it related to the termination of the August 20, 2015 Letter Agreement which was to provide advisory services, court filing fees, discovery and other litigation costs.  The revised Contingent Fee Agreement assumed the responsibility for the costs and expenses in the Terminated August 20, 2015 Letter Agreement and provides for the payment of twenty percent (20%) of all gross Licensing Agreement Proceeds and thirty percent (30%) of all Litigation Proceeds received by AVRS.  In addition, if the Litigation Proceeds agreed to or received by AVRS at any time are $100,000 or less then Legal Representative shall receive forty percent (40%) of the Litigation Proceeds.</p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;color:#000000;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify">On June 21, 2018, Advanced Voice Recognition Systems, Inc. (“<span style="border-bottom:1px solid #000000">AVRS</span>”) and Buether Joe &amp; Carpenter, LLC (“BJC) entered into a Letter of Engagement for Legal Services Limited Scope Agreement (“<span style="border-bottom:1px solid #000000">Agreement</span>”) with Schmeiser, Olsen &amp; Watts LLP (“<span style="border-bottom:1px solid #000000">the Firm</span>”) pursuant to which the Firm will serve as local counsel in the United States District Court, District of Arizona.  The Firm has been hired to represent AVRS as local counsel in connection with forthcoming litigation in the U.S. District Court, District of Arizona.    AVRS may terminate the Agreement at any time.</p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-align:justify">On July 22, 2019 Apple, Inc. submitted a petition for Inter Partes Review (IPR) of the AVRS patent.  It was ordered in the case of AVRS, Inc. v. Apple Inc (Case No. 2-18-cv-2083) that the parties’ stipulation was granted and the case is stayed pending the resolution of the IPR proceeding.  Buether Joe and Carpenter, LLC (BJC), our representation in the AVRS v. Apple litigation represents AVRS in the IPR. The IPR response to the Patent Trial and Appeal Board (PTAB) was done November 8, 2019.  On January 13, 2021, the United States Patent and Trademark Office Patent Trial and Appeal Board (PTAB) issued a Final Written Decision under 35 U.S.C. § 318(a) in <i>Inter Partes Review</i> petitioned by Apple Inc.  The decision found that claims 15 and 17 of AVRS’s U.S. Patent No. 7,558,730 B2 were invalid under 35 U.S.C. § 103(a).   On March 17, 2021, AVRS filed an appeal to the United States Court of Appeals for the Federal Circuit Docket Number 2021-1745. AVRS appeals the Patent Trial and Appeal Boards (“PTAB”) Final Written Decision on January 13, 2021 in the Inter Partes Review (IPR 2019-01352) petitioned by Apple, Inc of U. S. Patent No. 7,558,730.  The Federal Docket was argued in the Court of Appeals in December 2021.   Oral arguments were held on March 10, 2022.  On March 15, 2022, the United States Court of Appeals for the Federal Circuit issued a Judgement Affirming the United States Patent and Trademark Office, Patent Trial and Appeal Board in No. IPR2019-01352.  The decision found that claims 15 and 17, the only claims challenged by Apple out of a total of 18 claims of Advanced Voice Recognition Systems, Inc. (AVRS) U.S. Patent No. 7,558,730 B2 were invalid under 35 U.S.C. § 103(a). AVRS is exploring all options to enforce and monetize our patent portfolio by way of patent enforcement litigation and licensing agreements as well as developing new patents in the Voice Recognition Industry.</p>
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-335099 usd
us-gaap Revenues
Revenues
0 usd
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
46000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify"><b><i>Use of Estimates</i></b></p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify"> </p> <p style="font:10pt Times New Roman;margin:0;text-indent:0.8pt;text-align:justify">The preparation of financial statements in accordance with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
152 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12148 usd
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
162381 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
162380 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
4071 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
117 usd
CY2022Q3 fil Advance From Related Party
AdvanceFromRelatedParty
33493 usd
CY2021Q3 fil Advance From Related Party
AdvanceFromRelatedParty
14700 usd

Files In Submission

Name View Source Status
0001376474-22-000453-index-headers.html Edgar Link pending
0001376474-22-000453-index.html Edgar Link pending
0001376474-22-000453.txt Edgar Link pending
0001376474-22-000453-xbrl.zip Edgar Link pending
avoi-20220930.htm Edgar Link pending
avoi-20220930.xsd Edgar Link pending
avrs_ex31z1.htm Edgar Link pending
avrs_ex31z2.htm Edgar Link pending
avrs_ex32z1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
avoi-20220930_lab.xml Edgar Link unprocessable
avoi-20220930_def.xml Edgar Link unprocessable
avoi-20220930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
avoi-20220930_htm.xml Edgar Link completed
avoi-20220930_cal.xml Edgar Link unprocessable